HLA-C*06:02 status is a predictive biomarker that influences response to adalimumab and ustekinumab in patients with psoriasis.

The 15 risk loci linked to acne vulgaris in this study account for approximately 3% of phenotypic variance.

The median total charges submitted to Medicare increased, but there was not a significant increase in the actual amount paid from Medicare.

Desoximetasone with and without phone reminders was associated with clinical improvement in both psoriasis and atopic dermatitis.

The rate of treatment success with tapinarof cream 1% applied twice daily was statistically significantly higher than the rate achieved with vehicle cream.

Fixed-combination HP/TAZ lotion to manage moderate to severe plaque psoriasis was effective and superior to individual active ingredients.

For facial assessments, the investigators found a significant improvement in GAIS scores across all time points from baseline to week 12.

Further assessment is needed to determine the efficacy of oral isotretinoin for acne that has not responded to oral antibiotics plus topical agents, as well as different dose/regimens of oral isotretinoin in acne of all severities.

Investigators obtained and evaluated digital dermoscopic images of 136 histopathologically confirmed cases of cutaneous smooth muscle neoplasms.

Study investigators sought to determine if erythema assessment and percentage of ≥1-grade CEA improvement over time altered when assessment included a baseline facial photograph.